|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-36S1
|
$125,000
|
$3,750
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-36
|
$2,600,006
|
$78,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-07S1
|
$37,430
|
$749
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
$31,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Viruses and Cancer
|
5T32CA060395-20
|
$279,893
|
$69,973
|
LUKACHER, ARON
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Viral Oncology Training Grant
|
5T32CA009111-37
|
$373,216
|
$111,965
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral Non-Coding RNAs and Cell Transformation
|
1R01CA193300-01
|
$271,516
|
$92,315
|
STEITZ, JOAN
|
YALE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$3,743
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$12,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$428,850
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S1
|
$62,500
|
$10,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S2
|
$50,000
|
$8,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-40
|
$6,231,178
|
$996,988
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-02
|
$109,027
|
$54,514
|
OGEMBO, JAVIER
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Transcriptomic and Proteomic Approaches to Discovering Viral Causes for Human Hem
|
5R01CA170354-04
|
$341,947
|
$85,487
|
CHANG, YUAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Training In Tumor Virology
|
5T32CA115299-10
|
$342,954
|
$137,182
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
|
2R42CA153845-02
|
$1,227,385
|
$1,227,385
|
SAMPSON, JOHN
|
ANNIAS IMMUNOTHERAPEUTICS, INC.
|
|
The role of viral and cellular miRNAs in B-cell lymphomagenesis
|
5K99CA175181-02
|
$99,351
|
$99,351
|
SKALSKY, REBECCA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma
|
5R01CA184283-02
|
$512,013
|
$256,007
|
COBBS, CHARLES
|
SWEDISH MEDICAL CENTER, FIRST HILL
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-21S1
|
$79,482
|
$3,179
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-21
|
$4,814,560
|
$192,582
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The interaction of Burkitt's lymphoma cofactors EBV and Plasmodium
|
5F30CA168358-04
|
$47,591
|
$47,591
|
WOHLFORD, ERIC
|
UPSTATE MEDICAL UNIVERSITY
|
|
The Function of EBV LMP1 CTAR3 in Sumoylation and Oncogenesis
|
5R00CA160786-03
|
$249,000
|
$249,000
|
BENTZ, GRETCHEN
|
MERCER UNIVERSITY MACON
|
|
Temporal regulation of the essential Epstein-Barr virus oncoprotein LMP1
|
5F31CA180451-03
|
$33,389
|
$33,389
|
PRICE, ALEXANDER
|
DUKE UNIVERSITY
|
|
Targeting vFLIP for the treatment of KSHV-associated malignancies
|
5R01CA154228-05
|
$350,675
|
$350,675
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Targeting Tumorigenic Pathways in Glioblastoma with Oncolytic HSV
|
5R01CA160762-04
|
$355,522
|
$355,522
|
RABKIN, SAMUEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Targeting KSHV malignancies and persistent infection
|
1R01CA197153-01
|
$377,247
|
$377,247
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Studying the role of KSHV-encoded miRNAs
|
5R01CA119917-08
|
$301,913
|
$301,913
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$675,862
|
$608,275
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Stanford University Cancer Center
|
3P30CA124435-08S3
|
$2,249,153
|
$22,492
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
5R01CA170023-03
|
$392,517
|
$392,517
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Role of KSHV viral proteins in signaling and pathogenesis
|
5R01CA096500-13
|
$281,108
|
$281,108
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Role of B cells in murine gammaherpesvirus 68
|
2R01CA095318-11A1
|
$368,305
|
$368,305
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
2R01CA075922-19A1
|
$666,638
|
$666,638
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Regulation of KSHV Latency
|
5R01CA117830-10
|
$318,853
|
$318,853
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Regulation of KSHV infection and replication by MAPK pathways
|
5R01CA124332-09
|
$303,864
|
$303,864
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Regulation of EBV Latency by EBNA1
|
5R01CA093606-13
|
$321,273
|
$321,273
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Regional Oncology Research Center
|
3P30CA006973-52S1
|
$31,250
|
$313
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-52S2
|
$125,000
|
$1,250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-52S3
|
$185,800
|
$1,858
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-52
|
$6,995,267
|
$69,953
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
1R44CA192859-01A1
|
$300,000
|
$300,000
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Reactivation of Kaposi's Sarcoma-Associated Herpesvirus
|
5R01CA091791-13
|
$284,547
|
$284,547
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
POST-TRANSCRIPTIONAL GENE REGULATION BY EBV SM PROTEIN
|
5R01CA081133-15
|
$254,303
|
$254,303
|
SWAMINATHAN, SANKAR
|
UNIVERSITY OF UTAH
|
|
Plasma and serum biomarkers for Hodgkin lymphoma
|
5R21CA188824-02
|
$178,438
|
$44,610
|
AMBINDER, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Origin and Lineage of Differentiation of Kaposi's Sarcoma
|
1R21CA192744-01
|
$162,916
|
$162,916
|
SCHNEIDER, JOHANN
|
STELLENBOSCH UNIVERSITY TYGERBERG CAMPUS
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S1
|
$60,000
|
$4,200
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S2
|
$93,744
|
$6,562
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
5P30CA069533-18
|
$1,540,000
|
$107,800
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Novel oncolytic HSV-1 therapy for breast cancer meningeal metastases
|
5R21CA186054-02
|
$189,093
|
$189,093
|
KURUPPU, KUMUDU
|
MASSACHUSETTS GENERAL HOSPITAL
|
Total relevant funding to Herpes - Other for this search: $44,620,533
|